137 related articles for article (PubMed ID: 9713414)
1. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S118-31. PubMed ID: 9713414
[No Abstract] [Full Text] [Related]
2. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S160-77. PubMed ID: 9259700
[No Abstract] [Full Text] [Related]
3. Treatment modalities for ESRD patients. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S50-9. PubMed ID: 9713407
[No Abstract] [Full Text] [Related]
4. Analytical methods. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S142-62. PubMed ID: 9713417
[No Abstract] [Full Text] [Related]
5. Incidence and prevalence of ESRD. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S38-49. PubMed ID: 9713406
[No Abstract] [Full Text] [Related]
6. Incidence and prevalence of ESRD. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S40-53. PubMed ID: 9259692
[TBL] [Abstract][Full Text] [Related]
7. International comparisons of ESRD therapy. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S136-41. PubMed ID: 9713416
[No Abstract] [Full Text] [Related]
8. Hospitalization. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S109-17. PubMed ID: 9713413
[No Abstract] [Full Text] [Related]
9. Analytical methods. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S195-213. PubMed ID: 9259703
[No Abstract] [Full Text] [Related]
10. Pediatric end-stage renal disease. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S98-108. PubMed ID: 9713412
[No Abstract] [Full Text] [Related]
11. Annual facility survey of providers of ESRD therapy. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S132-5. PubMed ID: 9713415
[No Abstract] [Full Text] [Related]
12. Treatment modalities for ESRD patients. USRDS. United State Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S54-66. PubMed ID: 9259693
[No Abstract] [Full Text] [Related]
13. The social contract and the treatment of permanent kidney failure.
Rettig RA
JAMA; 1996 Apr; 275(14):1123-6. PubMed ID: 8601933
[No Abstract] [Full Text] [Related]
14. Renal transplantation: access and outcomes. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S89-97. PubMed ID: 9713411
[No Abstract] [Full Text] [Related]
15. Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S60-8. PubMed ID: 9713408
[No Abstract] [Full Text] [Related]
16. Pediatric end-stage renal disease. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S128-44. PubMed ID: 9259698
[No Abstract] [Full Text] [Related]
17. International comparisons of ESRD therapy. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S187-94. PubMed ID: 9259702
[No Abstract] [Full Text] [Related]
18. Is HCFA's reimbursement policy controlling quality of care for end-stage renal disease patients?
Lockridge RS; McKinney JK
ASAIO J; 2001; 47(5):466-8. PubMed ID: 11575817
[No Abstract] [Full Text] [Related]
19. X. The economic cost of ESRD and Medicare spending for alternative modalities of treatment.
Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S124-39. PubMed ID: 10431009
[No Abstract] [Full Text] [Related]
20. Causes of death. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S81-8. PubMed ID: 9713410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
